中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2015年
4期
59-62
,共4页
巴戟天多糖%骨质疏松%5-HT%VEGF%血清P
巴戟天多糖%骨質疏鬆%5-HT%VEGF%血清P
파극천다당%골질소송%5-HT%VEGF%혈청P
Morinda officinalis polysaccharides%osteoporosis%5-HT%VEGF%serum P
目的:探究巴戟天多糖对骨质疏松模型大鼠5-HT、VEGF与体内矿物质含量影响。方法健康清洁级雄性SD大鼠90只,随机选取15只为正常对照组,其余大鼠进行骨质疏松模型复制。模型复制成功后根据不同处理方式分为模型对照组组、巴戟天高剂量组、巴戟天中剂量组、巴戟天低剂量组及阳性药组。干预4周后比较各组大鼠骨密度、5-HT、VEGF及机体矿物质水平。结果与正常对照组比较,模型对照组与低剂量组BMD较低,提示骨质疏松仍然存在;与阳性药组比较,中剂量与高剂量BMD值较高( P<0.05)。与模型对照组比较,阳性药组、高剂量组与中剂量组5-HT水平较高,与阳性药组比较,中剂量组与高剂量组5-HT水平较高(P<0.05);与模型组比较,阳性药组、中剂量组与高剂量组VEGF水平较高,与阳性药组比较,中剂量组与高剂量组VEGF水平较高( P<0.05);与模型对照组比较,阳性药组、中剂量组与高剂量组血清P含量较高,与阳性药比较,中剂量组与高剂量组含量较高( P<0.05)。结论巴戟天多糖能升高骨质疏松模型大鼠5-HT、VEGF的含量,改善血清P水平,对临床有指导意义。
目的:探究巴戟天多糖對骨質疏鬆模型大鼠5-HT、VEGF與體內礦物質含量影響。方法健康清潔級雄性SD大鼠90隻,隨機選取15隻為正常對照組,其餘大鼠進行骨質疏鬆模型複製。模型複製成功後根據不同處理方式分為模型對照組組、巴戟天高劑量組、巴戟天中劑量組、巴戟天低劑量組及暘性藥組。榦預4週後比較各組大鼠骨密度、5-HT、VEGF及機體礦物質水平。結果與正常對照組比較,模型對照組與低劑量組BMD較低,提示骨質疏鬆仍然存在;與暘性藥組比較,中劑量與高劑量BMD值較高( P<0.05)。與模型對照組比較,暘性藥組、高劑量組與中劑量組5-HT水平較高,與暘性藥組比較,中劑量組與高劑量組5-HT水平較高(P<0.05);與模型組比較,暘性藥組、中劑量組與高劑量組VEGF水平較高,與暘性藥組比較,中劑量組與高劑量組VEGF水平較高( P<0.05);與模型對照組比較,暘性藥組、中劑量組與高劑量組血清P含量較高,與暘性藥比較,中劑量組與高劑量組含量較高( P<0.05)。結論巴戟天多糖能升高骨質疏鬆模型大鼠5-HT、VEGF的含量,改善血清P水平,對臨床有指導意義。
목적:탐구파극천다당대골질소송모형대서5-HT、VEGF여체내광물질함량영향。방법건강청길급웅성SD대서90지,수궤선취15지위정상대조조,기여대서진행골질소송모형복제。모형복제성공후근거불동처리방식분위모형대조조조、파극천고제량조、파극천중제량조、파극천저제량조급양성약조。간예4주후비교각조대서골밀도、5-HT、VEGF급궤체광물질수평。결과여정상대조조비교,모형대조조여저제량조BMD교저,제시골질소송잉연존재;여양성약조비교,중제량여고제량BMD치교고( P<0.05)。여모형대조조비교,양성약조、고제량조여중제량조5-HT수평교고,여양성약조비교,중제량조여고제량조5-HT수평교고(P<0.05);여모형조비교,양성약조、중제량조여고제량조VEGF수평교고,여양성약조비교,중제량조여고제량조VEGF수평교고( P<0.05);여모형대조조비교,양성약조、중제량조여고제량조혈청P함량교고,여양성약비교,중제량조여고제량조함량교고( P<0.05)。결론파극천다당능승고골질소송모형대서5-HT、VEGF적함량,개선혈청P수평,대림상유지도의의。
Objective To explore effect of 5-HT,VEGF and mineral content in osteoporosis rat by Morinda officinalis.Methods 90 SPF male SD rats were selected, 15 rats were randomly selected as the normal control group, the rest were to establish the model of osteoporosis.When the model was established successfully according to the different treatment methods were divided into control group, model group, positive medicine group, low, middle and high does group.Bone mineral density, 5-HT, VEGF and the levels of the mineral were compared after 4 weeks treatment.Results Compared with the normal control group, BMD of model control group and low dose group was lower, Compared with the positive drug group, BMD of middle dose and high dose was higher ( P<0.05 ).Compared with model group,5-HT level of positive medicine group, high dose group and middle dose group was higher, compared with positive drug group, 5-HTP of middle dose group and high dose group was higher ( P <0.05 ).Compared with model group, positive drug group, VEGF levels of middle dose group and high dose group were higher(P <0.05), compared with positive drug group, VEGF of middle dose group and high dose group were higher(P<0.05), compared with model control group, positive drug group, serum P content of middle dose group was higher, compared with positive drug, serum P content of high dose group and high dose group was less.Conclusion Morindae Officinalis can increase 5-HT, VEGF in a rat model of osteoporosis, improve the level of serum P, has the guiding sense to the clinical.